Last reviewed · How we verify

Codeine/acetaminophen

Montefiore Medical Center · FDA-approved active Small molecule

Codeine is converted to morphine in the body to activate opioid receptors for pain relief, while acetaminophen inhibits prostaglandin synthesis to reduce pain and fever.

Codeine is converted to morphine in the body to activate opioid receptors for pain relief, while acetaminophen inhibits prostaglandin synthesis to reduce pain and fever. Used for Moderate acute pain, Moderate chronic pain.

At a glance

Generic nameCodeine/acetaminophen
Also known asTylenol with codeine
SponsorMontefiore Medical Center
Drug classOpioid analgesic combination
TargetMu-opioid receptor (codeine); COX enzymes (acetaminophen)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Codeine is a prodrug opioid agonist that undergoes hepatic metabolism (primarily via CYP2D6) to morphine, which binds mu-opioid receptors in the central nervous system to produce analgesia. Acetaminophen works through a separate mechanism by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin production, providing additional analgesic and antipyretic effects. The combination provides synergistic pain relief for moderate pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: